Cargando…

Prevalence and Risk Factors for Diabetic Peripheral Neuropathy Among Saudi Hospitalized Diabetic Patients: A Nested Case-Control Study

OBJECTIVE: To determine the prevalence and the risk factors of diabetic peripheral neuropathy (DPN) in hospitalized adult Saudi diabetics. METHODS: This is a retrospective, nested case-control study conducted at King Abdulaziz Medical City (KAMC) in Riyadh, Saudi Arabia. All diabetic patients admitt...

Descripción completa

Detalles Bibliográficos
Autores principales: Aleidan, Fahad A S, Ahmad, Banderi A, Alotaibi, Farah A, Aleesa, Dalal H, Alhefdhi, Nuha A, Badri, Motasim, Abdel Gader, Abdel Galil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584505/
https://www.ncbi.nlm.nih.gov/pubmed/33116780
http://dx.doi.org/10.2147/IJGM.S273807
_version_ 1783599606422044672
author Aleidan, Fahad A S
Ahmad, Banderi A
Alotaibi, Farah A
Aleesa, Dalal H
Alhefdhi, Nuha A
Badri, Motasim
Abdel Gader, Abdel Galil
author_facet Aleidan, Fahad A S
Ahmad, Banderi A
Alotaibi, Farah A
Aleesa, Dalal H
Alhefdhi, Nuha A
Badri, Motasim
Abdel Gader, Abdel Galil
author_sort Aleidan, Fahad A S
collection PubMed
description OBJECTIVE: To determine the prevalence and the risk factors of diabetic peripheral neuropathy (DPN) in hospitalized adult Saudi diabetics. METHODS: This is a retrospective, nested case-control study conducted at King Abdulaziz Medical City (KAMC) in Riyadh, Saudi Arabia. All diabetic patients admitted to the hospital between the January 1, and December 31, 2018 were considered for inclusion in the study. Patients with DPN were identified and three controls per case were randomly selected from the remaining diabetic patients without peripheral neuropathy (PN). RESULTS: A total of 2,096 adult diabetic patients were identified during the study period. Of these, 73 patients (3.5%) were confirmed to be suffering from DPN and 219 were included as controls. When comparing diabetic with the control cases, DPN cases were significantly older (p=0.002), had a significantly higher proportion of type 2 diabetes (p=0.023), chronic kidney disease (p<0.0001), cerebral vascular stroke (p=0.027), hypertension (p=0.005), dyslipidemia (p=0.002), peripheral vascular disease (p<0.0001), osteoarthritis (p=0.034), diabetic ketoacidosis (p=0.003), foot ulcers (p=0.006), gangrene (p=0.001), lower limb ischemia (p=0.001), increased duration with diabetic disease (p=0.031), increased BMI (p=0.003), higher serum creatinine (p<0.001) and lower serum albumin levels (p=0.035). In the multivariate logistic regression, only older age {odds ratio (OR) 1.02, 95% CI 1.01–1.04, p=0.031}, chronic kidney disease (OR 2.39, 95% CI 1.23–4.64, p=0.010) and peripheral vascular disease (OR 3.14, 95% CI 1.39–7.13, p=0.006) were independently associated with DPN. CONCLUSION: This study identified several risk factors that contributed to the development of DPN in Saudis. These must be considered in strategies and campaigns aimed at risk reduction of cardiovascular and chronic diseases, and consequently progression of DPN.
format Online
Article
Text
id pubmed-7584505
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75845052020-10-27 Prevalence and Risk Factors for Diabetic Peripheral Neuropathy Among Saudi Hospitalized Diabetic Patients: A Nested Case-Control Study Aleidan, Fahad A S Ahmad, Banderi A Alotaibi, Farah A Aleesa, Dalal H Alhefdhi, Nuha A Badri, Motasim Abdel Gader, Abdel Galil Int J Gen Med Original Research OBJECTIVE: To determine the prevalence and the risk factors of diabetic peripheral neuropathy (DPN) in hospitalized adult Saudi diabetics. METHODS: This is a retrospective, nested case-control study conducted at King Abdulaziz Medical City (KAMC) in Riyadh, Saudi Arabia. All diabetic patients admitted to the hospital between the January 1, and December 31, 2018 were considered for inclusion in the study. Patients with DPN were identified and three controls per case were randomly selected from the remaining diabetic patients without peripheral neuropathy (PN). RESULTS: A total of 2,096 adult diabetic patients were identified during the study period. Of these, 73 patients (3.5%) were confirmed to be suffering from DPN and 219 were included as controls. When comparing diabetic with the control cases, DPN cases were significantly older (p=0.002), had a significantly higher proportion of type 2 diabetes (p=0.023), chronic kidney disease (p<0.0001), cerebral vascular stroke (p=0.027), hypertension (p=0.005), dyslipidemia (p=0.002), peripheral vascular disease (p<0.0001), osteoarthritis (p=0.034), diabetic ketoacidosis (p=0.003), foot ulcers (p=0.006), gangrene (p=0.001), lower limb ischemia (p=0.001), increased duration with diabetic disease (p=0.031), increased BMI (p=0.003), higher serum creatinine (p<0.001) and lower serum albumin levels (p=0.035). In the multivariate logistic regression, only older age {odds ratio (OR) 1.02, 95% CI 1.01–1.04, p=0.031}, chronic kidney disease (OR 2.39, 95% CI 1.23–4.64, p=0.010) and peripheral vascular disease (OR 3.14, 95% CI 1.39–7.13, p=0.006) were independently associated with DPN. CONCLUSION: This study identified several risk factors that contributed to the development of DPN in Saudis. These must be considered in strategies and campaigns aimed at risk reduction of cardiovascular and chronic diseases, and consequently progression of DPN. Dove 2020-10-16 /pmc/articles/PMC7584505/ /pubmed/33116780 http://dx.doi.org/10.2147/IJGM.S273807 Text en © 2020 Aleidan et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Aleidan, Fahad A S
Ahmad, Banderi A
Alotaibi, Farah A
Aleesa, Dalal H
Alhefdhi, Nuha A
Badri, Motasim
Abdel Gader, Abdel Galil
Prevalence and Risk Factors for Diabetic Peripheral Neuropathy Among Saudi Hospitalized Diabetic Patients: A Nested Case-Control Study
title Prevalence and Risk Factors for Diabetic Peripheral Neuropathy Among Saudi Hospitalized Diabetic Patients: A Nested Case-Control Study
title_full Prevalence and Risk Factors for Diabetic Peripheral Neuropathy Among Saudi Hospitalized Diabetic Patients: A Nested Case-Control Study
title_fullStr Prevalence and Risk Factors for Diabetic Peripheral Neuropathy Among Saudi Hospitalized Diabetic Patients: A Nested Case-Control Study
title_full_unstemmed Prevalence and Risk Factors for Diabetic Peripheral Neuropathy Among Saudi Hospitalized Diabetic Patients: A Nested Case-Control Study
title_short Prevalence and Risk Factors for Diabetic Peripheral Neuropathy Among Saudi Hospitalized Diabetic Patients: A Nested Case-Control Study
title_sort prevalence and risk factors for diabetic peripheral neuropathy among saudi hospitalized diabetic patients: a nested case-control study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584505/
https://www.ncbi.nlm.nih.gov/pubmed/33116780
http://dx.doi.org/10.2147/IJGM.S273807
work_keys_str_mv AT aleidanfahadas prevalenceandriskfactorsfordiabeticperipheralneuropathyamongsaudihospitalizeddiabeticpatientsanestedcasecontrolstudy
AT ahmadbanderia prevalenceandriskfactorsfordiabeticperipheralneuropathyamongsaudihospitalizeddiabeticpatientsanestedcasecontrolstudy
AT alotaibifaraha prevalenceandriskfactorsfordiabeticperipheralneuropathyamongsaudihospitalizeddiabeticpatientsanestedcasecontrolstudy
AT aleesadalalh prevalenceandriskfactorsfordiabeticperipheralneuropathyamongsaudihospitalizeddiabeticpatientsanestedcasecontrolstudy
AT alhefdhinuhaa prevalenceandriskfactorsfordiabeticperipheralneuropathyamongsaudihospitalizeddiabeticpatientsanestedcasecontrolstudy
AT badrimotasim prevalenceandriskfactorsfordiabeticperipheralneuropathyamongsaudihospitalizeddiabeticpatientsanestedcasecontrolstudy
AT abdelgaderabdelgalil prevalenceandriskfactorsfordiabeticperipheralneuropathyamongsaudihospitalizeddiabeticpatientsanestedcasecontrolstudy